Creative Structures for Keeping Innovation Alive After the Deal
June 03, 2024
Breakout Session

29AB
Life sciences transactions often focus on innovation and keeping that innovation alive is critical to ongoing success. In this panel, panelists will explore several different M&A and licensing models for keeping the innovation engine going including: acquired companies operating independently; option deals that maintain autonomy up to a certain development phase; milestone payments and contingent value rights; and employee retention plans. The session will engage our esteemed panelists from the pharma and biotech sectors, on their and their companies’ experiences and lessons learned, including a discussion on the M&A and licensing tactics that have been most successful.
Speakers
Speakers